Sygnature Discovery has received Crédit d’Impôt Recherche (CIR) accreditation from the French Ministère de l’Éducation nationale, de l’Enseignement supérieur et de la Recherche. This accreditation allows French companies to benefit from significant tax relief on drug discovery research undertaken by Sygnature on their behalf. http://www.education.gouv.fr/
Sygnature Discovery are sponsoring OBN’s PharmaTuesday industry debate on Pharma Externalisation on April 14th 2015
OBN PharmaTuesday – Should Pharma Externalization go to 100%? Chesterford Research Park, Little Chesterford, CB10 1XL Tuesday, 14 April 2015 from 18:00 to 21:30 Senior speakers from all sides of the industry will debate the contentious question whether biotech really can afford for big pharma to externalise R&D completely. Paul Clewlow, Senior Vice President – […]
LATi Chemistry Showcase taking place at Charnwood Biomedical Campus , Loughborough on 12th March 2015. ELRIG “Research and Innovation 2015″ taking place at Trent Vineyard , Nottingham on 18th March 2015.
BioCity-based Sygnature Discovery has kicked off 2015 by strengthening its senior team and bringing new services in-house. Dr Tim Schulz-Utermoehl, having previously worked for Shire Pharmaceuticals and AstraZeneca, is heading up the new DMPK department at Sygnature. As Director of DMPK Tim will be responsible for providing consultation for our clients and building a team […]
C4X Discovery to present at 3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
C4X Discovery’s Dr Thorsten Nowak is to give two presentations and poster at the 3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing (San Francisco, USA – 8-10 December 2014). Sygnature Discovery provided medicinal chemistry and in vitro biology support to C4X Discovery during its drug discovery activities. For more information, go to: […]